Key Takeaways
- DocuSign delivered Q1 adjusted earnings per share of $1.09, surpassing the Street’s $1.00 projection, while revenue reached $830.2M versus expectations of $823.23M
- Shares declined approximately 5% in extended trading hours despite exceeding estimates
- Second quarter revenue outlook of $867M at the midpoint marginally exceeds the $866M analyst target
- Full-year fiscal 2027 revenue forecast midpoint of $3.496B offers minimal upside versus the $3.49B Street estimate
- Jefferies upgraded its price objective to $50 from $45 while maintaining a Hold stance
DocuSign (DOCU) delivered results that exceeded Wall Street expectations for Q1 on both earnings and revenue, yet shares tumbled roughly 5% in after-hours trading as the company’s outlook provided limited reasons for optimism.
Shares had rallied 27% since hitting their February trough before the earnings release, setting the bar high for the quarter.
Adjusted earnings per share for Q1 registered at $1.09, topping the consensus forecast of $1.00. Total revenue came to $830.2 million, representing 9% year-over-year growth and beating the projected $823.23 million.
GAAP earnings stood at $0.40 per diluted share, an improvement from $0.34 in the corresponding period last year. The company’s non-GAAP gross margin edged down to 81.5% compared to 82.3% a year prior.
Free cash flow increased to $289.4 million from $227.8 million in the year-ago quarter. DocuSign also repurchased $317.5 million in shares, a significant jump from $183.4 million in the previous year’s period.
Forward Projections Offer Minimal Upside Potential
The company’s Q2 revenue outlook of $865M–$869M, with a midpoint at $867M, barely exceeds the Street consensus of $866M. This type of guidance typically fails to generate positive momentum.
For the complete fiscal 2027 year, DocuSign projects revenue between $3.49B and $3.502B, placing the midpoint marginally above Wall Street’s $3.49B target. The implied growth trajectory, excluding currency impacts, stands at 7.1%–7.5%.
Dollar Net Retention remained steady at 102%, unchanged from the previous quarter — a metric under close scrutiny by market analysts.
IAM Adoption Expanding, But Skepticism Persists
The company’s Intelligent Agreement Management platform currently represents 12.6% of Annual Recurring Revenue, climbing from 10.8% at January’s conclusion. CEO Allan Thygesen reported that 40,000 customers expanded their IAM investments during Q1.
Morgan Stanley recognized the solid performance but emphasized that fundamental concerns persist: “IAM adoption is advancing, yet the financial inflection point remains constrained and the underlying economics remain too unclear to demonstrate a sustainable return to double-digit expansion.”
Wolfe Research shared similar concerns, noting that DNR holding at 102% leaves them “awaiting more definitive proof that IAM can fuel a consistent growth reacceleration.”
Jefferies lifted its price target from $45 to $50 after the revenue outperformance, though maintained its Hold rating. The firm observed that shares trade at approximately 10x calendar year 2027 earnings — representing the lowest valuation multiple across its mid-cap coverage group.
According to Jefferies, enterprise bookings within North America expanded at the strongest rate during the quarter.


